Clinical Trials
Braintumor Website

There are 22 trials:
Facility: University of California, San Francisco
NCT Trial Name# of Centers

NCT01480479

  Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
206

NCT02526017

  Study of FPA008 in Combination With Nivolumab in Patients With Selected Advanced Cancers
39

NCT01182350

  Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG)
23

NCT01421524

  Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma
22

NCT02564198

  A Study of Ramucirumab (LY3009806) in Children With Refractory Solid Tumors
19

NCT01734512

  PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children
14

NCT01748149

  Vemurafenib in Children With Recurrent/Refractory BRAFV600E-mutant Gliomas
14

NCT02337491

  Pembrolizumab +/- Bevacizumab for Recurrent GBM
8

NCT01339052

  Phase II Study of BKM120 for Subjects With Recurrent Glioblastoma
7

NCT02981940

  A Study of Abemaciclib in Recurrent Glioblastoma
7

NCT02852655

  A Pilot Surgical Trial To Evaluate Early Immunologic Pharmacodynamic Parameters For The PD-1 Checkpoint Inhibitor, Pembrolizumab (MK-3475), In Patients With Surgically Accessible Recurrent/Progressive Glioblastoma
6

NCT00826241

  Dose-Dense Temozolomide + Lapatinib for Recurrent Ependymoma
6

NCT01764529

  Modifiers of Disease Severity in Cerebral Cavernous Malformations
4

NCT02533921

  Does Outpatient Palliative Care Improve Patient-centered Outcomes in Parkinson's Disease?
3

NCT01821443

  A Single Arm Study of Neurocognitive Outcomes in Patients With Brain Metastases Managed With Stereotactic Radiosurgery (SRS)
1

NCT02023905

  Everolimus With and Without Temozolomide in Adult Low Grade Glioma
1

NCT02060890

  A Pilot Trial Testing the Feasibility of Molecular Profiling in Recurrent/Progressive Glioblastoma
1

NCT01731704

  Neurocognitive Outcomes In Patients Treated With Radiotherapy For Five Or More Brain Metastases
1

NCT01227434

  A Study of PD 0332991 in Patients With Recurrent Rb Positive Glioblastoma
1

NCT00734682

  A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas
1

NCT00823459

  Phase II Trial of RAD001 in Patients With Recurrent Low Grade Glioma
1

NCT02783495

  Feasibility And Efficacy Of An iPad-Based Cognitive Rehabilitation Program In Brain Tumor Patients
1



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites